Austar Lifesciences Schedules 22 May 2026 AGM, Proposes 20% Issuance Mandate and 10% Share Buy-Back

Bulletin Express19:04

Austar Lifesciences Limited has issued a notice convening its 2026 Annual General Meeting (AGM) for 10:00 a.m. on Friday, 22 May 2026, at the company’s Shanghai headquarters (Conference Room, Room 2010, 20/F, No. 1018 Changning Road, Changning District).

Key agenda items include: 1. Approval of the audited consolidated financial statements, directors’ report and auditor’s report for the year ended 31 December 2025. 2. Re-election of executive directors Mr Ho Kwok Keung (also Chairman and CEO), Madam Zhou Ning and Mr Bian Ce, together with the re-election of Madam Ji Lingling as non-executive director, and authorisation for the Board to determine directors’ remuneration. 3. Re-appointment of Moore CPA Limited as external auditor, with the Board authorised to fix its remuneration. 4. Granting of general mandates: • Share issuance mandate permitting the Board to allot and issue (or transfer out of treasury, where applicable) new shares up to 20% of the company’s issued share capital as at the date of the AGM, with authority to extend this limit by the number of shares repurchased. • Share buy-back mandate allowing repurchases of up to 10% of issued shares on recognised exchanges during the mandate period. • Extension mandate to increase the share issuance limit by the volume of any shares repurchased under the buy-back authority. 5. Adoption of a second amended and restated Articles of Association to replace the existing version, subject to shareholder approval via special resolution.

The share register will be closed from 18 May to 22 May 2026 (both days inclusive). Share transfers must be lodged with Tricor Investor Services Limited by 4:30 p.m. on 15 May 2026 to qualify for AGM attendance and voting. All resolutions will be decided by poll.

The current Board consists of four executive directors (Mr Ho Kwok Keung, Mr Ho Kin Hung, Madam Zhou Ning, Mr Bian Ce), one non-executive director (Madam Ji Lingling) and three independent non-executive directors (Mr Cheung Lap Kei, Madam Chiu Hoi Shan, Mr Leung Oi Kin).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment